Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker AORT
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Oct 27, 2026 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | BlackRock, Inc. | 7.16M | 14.7% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | Nomura Investment Management Business Trust | 3.18M | 6.5% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | Nomura Asset Management International Inc. | 3.18M | 6.5% | SCHEDULE 13G/A ↗ |
| Aug 6, 2026 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | Abigail P. Johnson | 1.96M | 4.0% | SCHEDULE 13G/A ↗ |
| Aug 6, 2026 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | FMR LLC | 1.96M | 4.0% | SCHEDULE 13G/A ↗ |
| Mar 26, 2026 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | The Vanguard Group | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G | AORT Artivion, Inc. | Nomura Investment Management Business Trust | 2.61M | 5.5% | SCHEDULE 13G ↗ |
| Feb 17, 2026 | SCHEDULE 13G | AORT Artivion, Inc. | Nomura Asset Management International Inc. | 2.61M | 5.5% | SCHEDULE 13G ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | Macquarie Investment Management Business Trust | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | Macquarie Management Holdings Inc | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | Macquarie Group Limited | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | Perceptive Life Sciences Master Fund, Ltd. | 2.02M | 4.3% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | Joseph Edelman | 2.02M | 4.3% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | Perceptive Advisors LLC | 2.02M | 4.3% | SCHEDULE 13G/A ↗ |
| Nov 13, 2025 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | Macquarie Investment Management Business Trust | 2.48M | 5.3% | SCHEDULE 13G/A ↗ |
| Nov 13, 2025 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | Macquarie Management Holdings Inc | 2.48M | 5.3% | SCHEDULE 13G/A ↗ |
| Nov 13, 2025 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | Macquarie Group Limited | 2.48M | 5.3% | SCHEDULE 13G/A ↗ |
| Nov 7, 2025 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | Morgan Stanley | 2.07M | 4.4% | SCHEDULE 13G/A ↗ |
| Oct 17, 2025 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | BlackRock, Inc. | 5.98M | 12.7% | SCHEDULE 13G/A ↗ |
| Aug 12, 2025 | SCHEDULE 13D/A (amended) | AORT Artivion, Inc. | John A. Bartholdson | 1.86M | 4.0% | SCHEDULE 13D/A ↗ |
| Aug 12, 2025 | SCHEDULE 13D/A (amended) | AORT Artivion, Inc. | Alexis P. Michas | 1.86M | 4.0% | SCHEDULE 13D/A ↗ |
| Aug 12, 2025 | SCHEDULE 13D/A (amended) | AORT Artivion, Inc. | Juniper Investment Company, LLC | 1.86M | 4.0% | SCHEDULE 13D/A ↗ |
| Aug 12, 2025 | SCHEDULE 13D/A (amended) | AORT Artivion, Inc. | Juniper HF Investors, LLC | 13,485 | 0.0% | SCHEDULE 13D/A ↗ |
| Aug 12, 2025 | SCHEDULE 13D/A (amended) | AORT Artivion, Inc. | Juniper Multi-Strategy Fund, L.P. | 13,485 | 0.0% | SCHEDULE 13D/A ↗ |
| Aug 12, 2025 | SCHEDULE 13D/A (amended) | AORT Artivion, Inc. | Juniper Targeted Opportunity Investors, LLC | 377,308 | 0.8% | SCHEDULE 13D/A ↗ |
| Aug 12, 2025 | SCHEDULE 13D/A (amended) | AORT Artivion, Inc. | Juniper Targeted Opportunities, L.P. | 377,308 | 0.8% | SCHEDULE 13D/A ↗ |
| Aug 12, 2025 | SCHEDULE 13D/A (amended) | AORT Artivion, Inc. | Juniper HF Investors II, LLC | 1.47M | 3.1% | SCHEDULE 13D/A ↗ |
| Aug 12, 2025 | SCHEDULE 13D/A (amended) | AORT Artivion, Inc. | Juniper Targeted Opportunity Fund, L.P. | 1.47M | 3.1% | SCHEDULE 13D/A ↗ |
| Aug 6, 2025 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | Abigail P. Johnson | 2.29M | 5.4% | SCHEDULE 13G/A ↗ |
| Aug 6, 2025 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | FMR LLC | 2.29M | 5.4% | SCHEDULE 13G/A ↗ |
| Jul 21, 2025 | SCHEDULE 13G/A (amended) | AORT Artivion, Inc. | BlackRock, Inc. | 5.95M | 13.9% | SCHEDULE 13G/A ↗ |
| May 12, 2025 | SCHEDULE 13G | AORT Artivion, Inc. | Abigail P. Johnson | 2.90M | 6.9% | SCHEDULE 13G ↗ |
| May 12, 2025 | SCHEDULE 13G | AORT Artivion, Inc. | FMR LLC | 2.90M | 6.9% | SCHEDULE 13G ↗ |
33 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 7:27 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances